Annual report pursuant to Section 13 and 15(d)

Goodwill and Other Intangible Assets (Tables)

v3.23.1
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Identifiable Assets Carrying Value

 

          As of December 31, 2022     As of December 31, 2021  
    Life     Carrying     Carrying  
    (Years)     Amount     Amount  
                   
Asuragen acquisition:                        
Thyroid     9     $ 8,519     $ 8,519  
RedPath acquisition:                        
Pancreas test     7       16,141       16,141  
Barrett’s test     9       6,682       6,682  
                         
CLIA Lab     2.3       609       609  
                         
Total           $ 31,951     $ 31,951  
                         
Accumulated Amortization             (31,090 )     (29,819 )
                         
Net Carrying Value           $ 861     $ 2,132